Market Outlook
The global Drug-Device Combination Products market size was valued at USD 36220 million in 2022 and is forecast to a readjusted size of USD 54360 million by 2029 with a CAGR of 6.0% during review period.
Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.
Global key drug-device combination products players include GSK, Novo Nordisk and Eli Lilly etc. The top 3 companies hold a share about 32%. North America is the largest market with a share about 42%, followed by Europe and Asia-Pacific. In terms of product, nebulizer & inhaler is the largest segment with a share about 36%. And in terms of applications, the largest application is hospital and clinic with a share about 47%.
This report is a detailed and comprehensive analysis for global Drug-Device Combination Products market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Drug-Device Combination Products market size and forecasts, in consumption value ($ Million), 2018-2029
Global Drug-Device Combination Products market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Drug-Device Combination Products market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Drug-Device Combination Products market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug-Device Combination Products
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug-Device Combination Products market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
GSK
Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
Boston Scientific
Abbott
Boehringer Ingelheim
Medtronic
Mylan
3M
Hisamitsu
Smith & Nephew
Molnlycke
Teleflex
BD
Lepu Medical
MicroPort
Terumo
B. Braun
Antares Pharma
Segmentation By Type
Drug-Coated Device
Prefilled Drug Delivery Systems
Nebulizer and Inhaler
Transdermal Delivery System
Others
Segmentation By Application
Hospital and Clinic
Retail Pharmacies
Other
Segmentation By Region
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Drug-Device Combination Products Market in 2025?
The market will benefit from increased demand for personalized medicine and advancements in technology. Drug-device combinations can offer more effective treatments by improving patient adherence and convenience, making them highly attractive to both patients and healthcare providers. This growing trend will fuel innovation and product development.
What weaknesses might impact the Drug-Device Combination Products Market?
The complexity of regulatory approvals remains a challenge, as combining drugs and devices often requires navigating both pharmaceutical and medical device regulations. This can slow down product development and increase costs. Additionally, there may be challenges with reimbursement policies and market acceptance.
What opportunities exist for the Drug-Device Combination Products Market in 2025?
There is a significant opportunity for growth due to the increasing prevalence of chronic diseases, which require more advanced treatment solutions. As technology improves, the market can also capitalize on integrating digital health solutions with combination products. Expansion into emerging markets is another key opportunity as healthcare infrastructure improves globally.
What threats could affect the Drug-Device Combination Products Market?
Intense competition from both traditional pharmaceuticals and standalone medical devices can pose a threat. Intellectual property issues and the risk of counterfeit products may also undermine market growth. Furthermore, economic downturns or changes in healthcare policies could reduce investment in innovation and product development.
Market PESTEL Analysis
How will political factors impact the Drug-Device Combination Products Market in 2025?
Political stability and government policies on healthcare funding will play a critical role. Regulatory frameworks and government approval processes for drug-device combinations will either facilitate or hinder market growth. Additionally, changes in reimbursement policies or healthcare reforms could affect the affordability and accessibility of these products.
What economic factors could influence the Drug-Device Combination Products Market?
Economic conditions such as healthcare budgets, consumer purchasing power, and global economic stability will have a significant impact. In times of economic downturn, healthcare spending might be reduced, affecting the adoption of expensive combination products. On the other hand, economic growth in emerging markets may open up new opportunities for market expansion.
How do social factors affect the Drug-Device Combination Products Market?
Social trends like an aging population, rising awareness of chronic conditions, and demand for more convenient treatments will drive market growth. As patients seek better outcomes, especially in the home healthcare sector, drug-device combinations that improve convenience and compliance will gain popularity.
What technological factors are shaping the Drug-Device Combination Products Market?
Technological advancements in both drug delivery systems and medical devices will significantly shape the market. Innovations like digital health integration, personalized medicine, and improved materials for drug-device combinations can enhance the efficacy and patient experience, thus driving adoption and market growth.
What environmental factors could impact the Drug-Device Combination Products Market?
Environmental factors, including sustainability and eco-friendly manufacturing processes, are becoming more important in the healthcare sector. Manufacturers will need to address growing concerns about waste management and the environmental impact of their products. Additionally, climate change could influence disease patterns, driving the need for certain drug-device combinations.
What legal factors will influence the Drug-Device Combination Products Market?
Legal regulations related to intellectual property, product liability, and patent protections will be key factors. Strict regulatory guidelines for approval and safety standards will also shape product development. Compliance with both pharmaceutical and medical device laws will be a challenge for manufacturers looking to enter this market.
Market SIPOC Analysis
Who are the suppliers in the Drug-Device Combination Products Market in 2025?
Suppliers include pharmaceutical manufacturers, medical device companies, raw material providers (such as polymers, metals, and drug compounds), and technology developers for smart devices and digital health solutions. These suppliers are essential for providing the components and materials needed for the production of drug-device combinations.
What inputs are required for the Drug-Device Combination Products Market?
Key inputs involve raw materials for drugs and medical devices, research and development investments, regulatory approvals, technological advancements for device integration, and skilled labor to design and manufacture the combinations. Additionally, data from clinical trials and market research is crucial for product development and validation.
What is the process of developing Drug-Device Combination Products?
The development process involves designing the drug-device combination, conducting preclinical and clinical testing, obtaining necessary regulatory approvals, and manufacturing the products. It also includes product testing for efficacy, safety, and compatibility, as well as ensuring proper packaging and labeling for consumer use.
Who are the customers of Drug-Device Combination Products?
Customers include healthcare providers (hospitals, clinics, homecare settings), patients who require chronic disease management or personalized medicine, and pharmaceutical companies who distribute these products. Additionally, insurance companies and regulatory bodies are indirect customers, influencing access and market acceptance.
What are the outcomes of the Drug-Device Combination Products Market?
The outcomes are the successful development, approval, and adoption of innovative drug-device combination products. These products improve patient outcomes, enhance treatment adherence, and provide cost-effective solutions in chronic disease management. The market also generates revenue for manufacturers and expands access to advanced healthcare solutions.
Market Porter's Five Forces
How strong is the threat of new entrants in the Drug-Device Combination Products Market in 2025?
The threat of new entrants is moderate to high due to the high barriers to entry, such as strict regulatory requirements, large capital investment, and the need for extensive R&D. However, advancements in technology and increasing demand for innovative products may encourage new companies to enter the market, especially in niche segments.
How intense is the bargaining power of suppliers in the Drug-Device Combination Products Market?
The bargaining power of suppliers is moderate. While there are specialized suppliers for the materials and technologies required for drug-device combinations, the overall number of suppliers is growing. This allows companies to have more options, but critical components such as specialized drug delivery systems or patented technologies still give suppliers some leverage.
How high is the bargaining power of buyers in the Drug-Device Combination Products Market?
The bargaining power of buyers is moderate. Healthcare providers and patients have limited power over prices for drug-device combinations, as these products often offer unique value and may be covered by insurance. However, as the market grows and more alternatives become available, buyers will increasingly demand competitive pricing and better outcomes.
What is the threat of substitute products in the Drug-Device Combination Products Market?
The threat of substitutes is moderate to high. While drug-device combinations offer significant advantages in terms of patient compliance and treatment efficiency, other solutions such as standalone drugs or devices might serve as alternatives. New medical technologies and treatment methods can also disrupt the market, presenting substitutes for combination products.
How intense is the competitive rivalry in the Drug-Device Combination Products Market?
The competitive rivalry is high. The market is filled with established pharmaceutical and medical device companies competing to offer innovative and effective combination products. As technology advances and demand increases, companies will continue to vie for market share through product differentiation, innovation, and strategic partnerships.
Market Upstream Analysis
What are the key suppliers in the Drug-Device Combination Products Market?
Key suppliers include pharmaceutical companies for drug components, medical device manufacturers for delivery systems, raw material providers (such as polymers, metals, and biocompatible materials), and technology companies for integration of digital solutions or smart devices. These suppliers play a critical role in ensuring the quality and innovation of the combination products.
What are the essential inputs required in the Drug-Device Combination Products Market?
Essential inputs include raw materials for drugs and devices, R&D resources for developing combination products, regulatory expertise for navigating complex approval processes, and advanced manufacturing capabilities for combining drugs and devices. Additionally, clinical data and market research are critical inputs for ensuring product efficacy and market demand.
How do regulatory factors affect the upstream activities in the Drug-Device Combination Products Market?
Regulatory factors significantly impact upstream activities by dictating the standards for drug-device combinations. Strict regulatory approval processes, such as those from the FDA or EMA, require companies to follow specific guidelines and conduct extensive clinical trials. These regulations ensure product safety but also slow down development timelines and increase costs.
What technological advancements impact upstream activities in the Drug-Device Combination Products Market?
Technological advancements in both drug delivery systems and medical devices are crucial upstream drivers. Innovations in materials, miniaturization, and connectivity (such as digital health integrations) help enhance the functionality of drug-device combinations. Research and development of new technologies can result in improved patient outcomes and more efficient production processes.
What challenges do upstream stakeholders face in the Drug-Device Combination Products Market?
Upstream stakeholders face challenges such as high development costs, lengthy approval processes, and the need for specialized expertise in both pharmaceuticals and medical devices. Additionally, supply chain disruptions and the pressure to meet regulatory standards can hinder the smooth flow of materials and products.
Market Midstream Analysis
What are the key processes involved in the midstream activities of the Drug-Device Combination Products Market?
Midstream activities in the Drug-Device Combination Products Market involve the manufacturing and assembly of drug-device combinations. This includes integrating the pharmaceutical drug with the medical device, ensuring product compatibility, conducting quality control, and meeting regulatory standards. The manufacturing process requires coordination between pharmaceutical manufacturers, device producers, and regulatory bodies to ensure seamless product development.
How do manufacturing and assembly processes affect the Drug-Device Combination Products Market?
The manufacturing and assembly processes are critical in determining product quality, cost efficiency, and time to market. Efficient manufacturing techniques ensure that drug-device combinations are produced at scale while maintaining the high standards required for patient safety. Innovations in automated production, precision engineering, and regulatory compliance will play a significant role in optimizing these processes.
What role does quality control play in the midstream activities of the Drug-Device Combination Products Market?
Quality control is vital in ensuring that drug-device combinations meet the stringent regulatory standards for safety and effectiveness. It involves rigorous testing, including device performance, drug efficacy, and the overall functionality of the combination product. Any failure in quality control could delay product launches, result in costly recalls, or damage the product's reputation in the market.
What are the challenges in midstream activities for the Drug-Device Combination Products Market?
Midstream activities face challenges such as complex supply chain logistics, ensuring consistent product quality, and dealing with regulatory compliance across multiple regions. The integration of drug and device components also involves high levels of technical complexity, and any issues with material compatibility or performance can affect the final product. Additionally, maintaining cost-effectiveness while meeting stringent quality standards is a constant challenge for manufacturers.
How does regulatory approval impact midstream activities in the Drug-Device Combination Products Market?
Regulatory approval impacts midstream activities by requiring manufacturers to adhere to strict guidelines during production, packaging, and testing. Compliance with agencies like the FDA or EMA is essential for market entry, and the approval process may require additional rounds of testing and documentation. Delays in regulatory approvals can significantly impact production schedules and market availability.
Market Downstream Analysis
What are the key downstream activities in the Drug-Device Combination Products Market?
Downstream activities focus on distribution, sales, marketing, and post-market surveillance of drug-device combinations. This includes working with healthcare providers, pharmacies, and insurance companies to ensure product availability and reimbursement. Additionally, ongoing monitoring of product performance and patient outcomes is critical to maintaining regulatory compliance and supporting product improvements.
How do distribution and sales channels affect the Drug-Device Combination Products Market?
Distribution and sales channels are crucial for ensuring that drug-device combinations reach the appropriate healthcare settings, including hospitals, clinics, and pharmacies. Effective partnerships with distributors, as well as strong relationships with healthcare providers, are key to market penetration. Sales strategies will also need to address pricing, reimbursement, and patient accessibility to drive adoption.
What role does marketing play in the success of the Drug-Device Combination Products Market?
Marketing plays a significant role in raising awareness of the benefits of drug-device combinations among both healthcare professionals and patients. Highlighting the advantages, such as improved patient adherence and more effective treatments, will drive product demand. Digital marketing and education campaigns are also essential to reaching a broader audience and providing necessary training on usage.
What challenges do downstream stakeholders face in the Drug-Device Combination Products Market?
Downstream stakeholders face challenges such as navigating complex reimbursement policies, addressing market competition, and ensuring that products are used correctly by patients. Additionally, regulatory changes and the need for continuous education on new drug-device combination products can create barriers to widespread adoption. Managing post-market surveillance and responding to adverse events are also critical aspects of downstream activities.
How does post-market surveillance impact downstream activities in the Drug-Device Combination Products Market?
Post-market surveillance ensures that drug-device combinations remain safe and effective once they are launched. This includes collecting real-world data on product performance, monitoring for adverse reactions, and ensuring compliance with regulatory reporting requirements. Effective post-market surveillance supports ongoing product improvements and helps maintain market trust, which is essential for long-term success in the market.
Chapter 1, to describe Drug-Device Combination Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug-Device Combination Products, with revenue, gross margin and global market share of Drug-Device Combination Products from 2018 to 2023.
Chapter 3, the Drug-Device Combination Products competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Drug-Device Combination Products market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug-Device Combination Products.
Chapter 13, to describe Drug-Device Combination Products research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Drug-Device Combination Products
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Drug-Device Combination Products by Type
1.3.1 Overview: Global Drug-Device Combination Products Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Drug-Device Combination Products Consumption Value Market Share by Type in 2022
1.3.3 Drug-Coated Device
1.3.4 Prefilled Drug Delivery Systems
1.3.5 Nebulizer and Inhaler
1.3.6 Transdermal Delivery System
1.3.7 Others
1.4 Global Drug-Device Combination Products Market by Application
1.4.1 Overview: Global Drug-Device Combination Products Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital andClinic
1.4.3 Retail Pharmacies
1.4.4 Other
1.5 Global Drug-Device Combination Products Market Size & Forecast
1.6 Global Drug-Device Combination Products Market Size and Forecast by Region
1.6.1 Global Drug-Device Combination Products Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Drug-Device Combination Products Market Size by Region, (2018-2029)
1.6.3 North America Drug-Device Combination Products Market Size and Prospect (2018-2029)
1.6.4 Europe Drug-Device Combination Products Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Drug-Device Combination Products Market Size and Prospect (2018-2029)
1.6.6 South America Drug-Device Combination Products Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Drug-Device Combination Products Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Drug-Device Combination Products Product and Solutions
2.1.4 GSK Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GSK Recent Developments and Future Plans
2.2 Novo Nordisk
2.2.1 Novo Nordisk Details
2.2.2 Novo Nordisk Major Business
2.2.3 Novo Nordisk Drug-Device Combination Products Product and Solutions
2.2.4 Novo Nordisk Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novo Nordisk Recent Developments and Future Plans
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Drug-Device Combination Products Product and Solutions
2.3.4 Eli Lilly Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Eli Lilly Recent Developments and Future Plans
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca Drug-Device Combination Products Product and Solutions
2.4.4 AstraZeneca Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AstraZeneca Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Drug-Device Combination Products Product and Solutions
2.5.4 Sanofi Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 Boston Scientific
2.6.1 Boston Scientific Details
2.6.2 Boston Scientific Major Business
2.6.3 Boston Scientific Drug-Device Combination Products Product and Solutions
2.6.4 Boston Scientific Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Boston Scientific Recent Developments and Future Plans
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Drug-Device Combination Products Product and Solutions
2.7.4 Abbott Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Abbott Recent Developments and Future Plans
2.8 Boehringer Ingelheim
2.8.1 Boehringer Ingelheim Details
2.8.2 Boehringer Ingelheim Major Business
2.8.3 Boehringer Ingelheim Drug-Device Combination Products Product and Solutions
2.8.4 Boehringer Ingelheim Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Boehringer Ingelheim Recent Developments and Future Plans
2.9 Medtronic
2.9.1 Medtronic Details
2.9.2 Medtronic Major Business
2.9.3 Medtronic Drug-Device Combination Products Product and Solutions
2.9.4 Medtronic Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Medtronic Recent Developments and Future Plans
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Drug-Device Combination Products Product and Solutions
2.10.4 Mylan Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Mylan Recent Developments and Future Plans
2.11 3M
2.11.1 3M Details
2.11.2 3M Major Business
2.11.3 3M Drug-Device Combination Products Product and Solutions
2.11.4 3M Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 3M Recent Developments and Future Plans
2.12 Hisamitsu
2.12.1 Hisamitsu Details
2.12.2 Hisamitsu Major Business
2.12.3 Hisamitsu Drug-Device Combination Products Product and Solutions
2.12.4 Hisamitsu Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Hisamitsu Recent Developments and Future Plans
2.13 Smith & Nephew
2.13.1 Smith & Nephew Details
2.13.2 Smith & Nephew Major Business
2.13.3 Smith & Nephew Drug-Device Combination Products Product and Solutions
2.13.4 Smith & Nephew Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Smith & Nephew Recent Developments and Future Plans
2.14 Molnlycke
2.14.1 Molnlycke Details
2.14.2 Molnlycke Major Business
2.14.3 Molnlycke Drug-Device Combination Products Product and Solutions
2.14.4 Molnlycke Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Molnlycke Recent Developments and Future Plans
2.15 Teleflex
2.15.1 Teleflex Details
2.15.2 Teleflex Major Business
2.15.3 Teleflex Drug-Device Combination Products Product and Solutions
2.15.4 Teleflex Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Teleflex Recent Developments and Future Plans
2.16 BD
2.16.1 BD Details
2.16.2 BD Major Business
2.16.3 BD Drug-Device Combination Products Product and Solutions
2.16.4 BD Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 BD Recent Developments and Future Plans
2.17 Lepu Medical
2.17.1 Lepu Medical Details
2.17.2 Lepu Medical Major Business
2.17.3 Lepu Medical Drug-Device Combination Products Product and Solutions
2.17.4 Lepu Medical Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Lepu Medical Recent Developments and Future Plans
2.18 MicroPort
2.18.1 MicroPort Details
2.18.2 MicroPort Major Business
2.18.3 MicroPort Drug-Device Combination Products Product and Solutions
2.18.4 MicroPort Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 MicroPort Recent Developments and Future Plans
2.19 Terumo
2.19.1 Terumo Details
2.19.2 Terumo Major Business
2.19.3 Terumo Drug-Device Combination Products Product and Solutions
2.19.4 Terumo Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Terumo Recent Developments and Future Plans
2.20 B. Braun
2.20.1 B. Braun Details
2.20.2 B. Braun Major Business
2.20.3 B. Braun Drug-Device Combination Products Product and Solutions
2.20.4 B. Braun Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 B. Braun Recent Developments and Future Plans
2.21 Antares Pharma
2.21.1 Antares Pharma Details
2.21.2 Antares Pharma Major Business
2.21.3 Antares Pharma Drug-Device Combination Products Product and Solutions
2.21.4 Antares Pharma Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Antares Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Drug-Device Combination Products Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Drug-Device Combination Products by Company Revenue
3.2.2 Top 3 Drug-Device Combination Products Players Market Share in 2022
3.2.3 Top 6 Drug-Device Combination Products Players Market Share in 2022
3.3 Drug-Device Combination Products Market: Overall Company Footprint Analysis
3.3.1 Drug-Device Combination Products Market: Region Footprint
3.3.2 Drug-Device Combination Products Market: Company Product Type Footprint
3.3.3 Drug-Device Combination Products Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Drug-Device Combination Products Consumption Value and Market Share by Type (2018-2023)
4.2 Global Drug-Device Combination Products Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Drug-Device Combination Products Consumption Value Market Share by Application (2018-2023)
5.2 Global Drug-Device Combination Products Market Forecast by Application (2024-2029)
6 North America
6.1 North America Drug-Device Combination Products Consumption Value by Type (2018-2029)
6.2 North America Drug-Device Combination Products Consumption Value by Application (2018-2029)
6.3 North America Drug-Device Combination Products Market Size by Country
6.3.1 North America Drug-Device Combination Products Consumption Value by Country (2018-2029)
6.3.2 United States Drug-Device Combination Products Market Size and Forecast (2018-2029)
6.3.3 Canada Drug-Device Combination Products Market Size and Forecast (2018-2029)
6.3.4 Mexico Drug-Device Combination Products Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Drug-Device Combination Products Consumption Value by Type (2018-2029)
7.2 Europe Drug-Device Combination Products Consumption Value by Application (2018-2029)
7.3 Europe Drug-Device Combination Products Market Size by Country
7.3.1 Europe Drug-Device Combination Products Consumption Value by Country (2018-2029)
7.3.2 Germany Drug-Device Combination Products Market Size and Forecast (2018-2029)
7.3.3 France Drug-Device Combination Products Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Drug-Device Combination Products Market Size and Forecast (2018-2029)
7.3.5 Russia Drug-Device Combination Products Market Size and Forecast (2018-2029)
7.3.6 Italy Drug-Device Combination Products Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Drug-Device Combination Products Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Drug-Device Combination Products Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Drug-Device Combination Products Market Size by Region
8.3.1 Asia-Pacific Drug-Device Combination Products Consumption Value by Region (2018-2029)
8.3.2 China Drug-Device Combination Products Market Size and Forecast (2018-2029)
8.3.3 Japan Drug-Device Combination Products Market Size and Forecast (2018-2029)
8.3.4 South Korea Drug-Device Combination Products Market Size and Forecast (2018-2029)
8.3.5 India Drug-Device Combination Products Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Drug-Device Combination Products Market Size and Forecast (2018-2029)
8.3.7 Australia Drug-Device Combination Products Market Size and Forecast (2018-2029)
9 South America
9.1 South America Drug-Device Combination Products Consumption Value by Type (2018-2029)
9.2 South America Drug-Device Combination Products Consumption Value by Application (2018-2029)
9.3 South America Drug-Device Combination Products Market Size by Country
9.3.1 South America Drug-Device Combination Products Consumption Value by Country (2018-2029)
9.3.2 Brazil Drug-Device Combination Products Market Size and Forecast (2018-2029)
9.3.3 Argentina Drug-Device Combination Products Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Drug-Device Combination Products Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Drug-Device Combination Products Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Drug-Device Combination Products Market Size by Country
10.3.1 Middle East & Africa Drug-Device Combination Products Consumption Value by Country (2018-2029)
10.3.2 Turkey Drug-Device Combination Products Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Drug-Device Combination Products Market Size and Forecast (2018-2029)
10.3.4 UAE Drug-Device Combination Products Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Drug-Device Combination Products Market Drivers
11.2 Drug-Device Combination Products Market Restraints
11.3 Drug-Device Combination Products Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Drug-Device Combination Products Industry Chain
12.2 Drug-Device Combination Products Upstream Analysis
12.3 Drug-Device Combination Products Midstream Analysis
12.4 Drug-Device Combination Products Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Drug-Device Combination Products Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Drug-Device Combination Products Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Drug-Device Combination Products Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Drug-Device Combination Products Consumption Value by Region (2024-2029) & (USD Million)
Table 5. GSK Company Information, Head Office, and Major Competitors
Table 6. GSK Major Business
Table 7. GSK Drug-Device Combination Products Product and Solutions
Table 8. GSK Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. GSK Recent Developments and Future Plans
Table 10. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 11. Novo Nordisk Major Business
Table 12. Novo Nordisk Drug-Device Combination Products Product and Solutions
Table 13. Novo Nordisk Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Novo Nordisk Recent Developments and Future Plans
Table 15. Eli Lilly Company Information, Head Office, and Major Competitors
Table 16. Eli Lilly Major Business
Table 17. Eli Lilly Drug-Device Combination Products Product and Solutions
Table 18. Eli Lilly Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Eli Lilly Recent Developments and Future Plans
Table 20. AstraZeneca Company Information, Head Office, and Major Competitors
Table 21. AstraZeneca Major Business
Table 22. AstraZeneca Drug-Device Combination Products Product and Solutions
Table 23. AstraZeneca Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. AstraZeneca Recent Developments and Future Plans
Table 25. Sanofi Company Information, Head Office, and Major Competitors
Table 26. Sanofi Major Business
Table 27. Sanofi Drug-Device Combination Products Product and Solutions
Table 28. Sanofi Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Sanofi Recent Developments and Future Plans
Table 30. Boston Scientific Company Information, Head Office, and Major Competitors
Table 31. Boston Scientific Major Business
Table 32. Boston Scientific Drug-Device Combination Products Product and Solutions
Table 33. Boston Scientific Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Boston Scientific Recent Developments and Future Plans
Table 35. Abbott Company Information, Head Office, and Major Competitors
Table 36. Abbott Major Business
Table 37. Abbott Drug-Device Combination Products Product and Solutions
Table 38. Abbott Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Abbott Recent Developments and Future Plans
Table 40. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 41. Boehringer Ingelheim Major Business
Table 42. Boehringer Ingelheim Drug-Device Combination Products Product and Solutions
Table 43. Boehringer Ingelheim Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Boehringer Ingelheim Recent Developments and Future Plans
Table 45. Medtronic Company Information, Head Office, and Major Competitors
Table 46. Medtronic Major Business
Table 47. Medtronic Drug-Device Combination Products Product and Solutions
Table 48. Medtronic Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Medtronic Recent Developments and Future Plans
Table 50. Mylan Company Information, Head Office, and Major Competitors
Table 51. Mylan Major Business
Table 52. Mylan Drug-Device Combination Products Product and Solutions
Table 53. Mylan Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Mylan Recent Developments and Future Plans
Table 55. 3M Company Information, Head Office, and Major Competitors
Table 56. 3M Major Business
Table 57. 3M Drug-Device Combination Products Product and Solutions
Table 58. 3M Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. 3M Recent Developments and Future Plans
Table 60. Hisamitsu Company Information, Head Office, and Major Competitors
Table 61. Hisamitsu Major Business
Table 62. Hisamitsu Drug-Device Combination Products Product and Solutions
Table 63. Hisamitsu Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Hisamitsu Recent Developments and Future Plans
Table 65. Smith & Nephew Company Information, Head Office, and Major Competitors
Table 66. Smith & Nephew Major Business
Table 67. Smith & Nephew Drug-Device Combination Products Product and Solutions
Table 68. Smith & Nephew Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Smith & Nephew Recent Developments and Future Plans
Table 70. Molnlycke Company Information, Head Office, and Major Competitors
Table 71. Molnlycke Major Business
Table 72. Molnlycke Drug-Device Combination Products Product and Solutions
Table 73. Molnlycke Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Molnlycke Recent Developments and Future Plans
Table 75. Teleflex Company Information, Head Office, and Major Competitors
Table 76. Teleflex Major Business
Table 77. Teleflex Drug-Device Combination Products Product and Solutions
Table 78. Teleflex Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Teleflex Recent Developments and Future Plans
Table 80. BD Company Information, Head Office, and Major Competitors
Table 81. BD Major Business
Table 82. BD Drug-Device Combination Products Product and Solutions
Table 83. BD Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. BD Recent Developments and Future Plans
Table 85. Lepu Medical Company Information, Head Office, and Major Competitors
Table 86. Lepu Medical Major Business
Table 87. Lepu Medical Drug-Device Combination Products Product and Solutions
Table 88. Lepu Medical Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Lepu Medical Recent Developments and Future Plans
Table 90. MicroPort Company Information, Head Office, and Major Competitors
Table 91. MicroPort Major Business
Table 92. MicroPort Drug-Device Combination Products Product and Solutions
Table 93. MicroPort Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. MicroPort Recent Developments and Future Plans
Table 95. Terumo Company Information, Head Office, and Major Competitors
Table 96. Terumo Major Business
Table 97. Terumo Drug-Device Combination Products Product and Solutions
Table 98. Terumo Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Terumo Recent Developments and Future Plans
Table 100. B. Braun Company Information, Head Office, and Major Competitors
Table 101. B. Braun Major Business
Table 102. B. Braun Drug-Device Combination Products Product and Solutions
Table 103. B. Braun Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. B. Braun Recent Developments and Future Plans
Table 105. Antares Pharma Company Information, Head Office, and Major Competitors
Table 106. Antares Pharma Major Business
Table 107. Antares Pharma Drug-Device Combination Products Product and Solutions
Table 108. Antares Pharma Drug-Device Combination Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Antares Pharma Recent Developments and Future Plans
Table 110. Global Drug-Device Combination Products Revenue (USD Million) by Players (2018-2023)
Table 111. Global Drug-Device Combination Products Revenue Share by Players (2018-2023)
Table 112. Breakdown of Drug-Device Combination Products by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Drug-Device Combination Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 114. Head Office of Key Drug-Device Combination Products Players
Table 115. Drug-Device Combination Products Market: Company Product Type Footprint
Table 116. Drug-Device Combination Products Market: Company Product Application Footprint
Table 117. Drug-Device Combination Products New Market Entrants and Barriers to Market Entry
Table 118. Drug-Device Combination Products Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Drug-Device Combination Products Consumption Value (USD Million) by Type (2018-2023)
Table 120. Global Drug-Device Combination Products Consumption Value Share by Type (2018-2023)
Table 121. Global Drug-Device Combination Products Consumption Value Forecast by Type (2024-2029)
Table 122. Global Drug-Device Combination Products Consumption Value by Application (2018-2023)
Table 123. Global Drug-Device Combination Products Consumption Value Forecast by Application (2024-2029)
Table 124. North America Drug-Device Combination Products Consumption Value by Type (2018-2023) & (USD Million)
Table 125. North America Drug-Device Combination Products Consumption Value by Type (2024-2029) & (USD Million)
Table 126. North America Drug-Device Combination Products Consumption Value by Application (2018-2023) & (USD Million)
Table 127. North America Drug-Device Combination Products Consumption Value by Application (2024-2029) & (USD Million)
Table 128. North America Drug-Device Combination Products Consumption Value by Country (2018-2023) & (USD Million)
Table 129. North America Drug-Device Combination Products Consumption Value by Country (2024-2029) & (USD Million)
Table 130. Europe Drug-Device Combination Products Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Europe Drug-Device Combination Products Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Europe Drug-Device Combination Products Consumption Value by Application (2018-2023) & (USD Million)
Table 133. Europe Drug-Device Combination Products Consumption Value by Application (2024-2029) & (USD Million)
Table 134. Europe Drug-Device Combination Products Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Drug-Device Combination Products Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Drug-Device Combination Products Consumption Value by Type (2018-2023) & (USD Million)
Table 137. Asia-Pacific Drug-Device Combination Products Consumption Value by Type (2024-2029) & (USD Million)
Table 138. Asia-Pacific Drug-Device Combination Products Consumption Value by Application (2018-2023) & (USD Million)
Table 139. Asia-Pacific Drug-Device Combination Products Consumption Value by Application (2024-2029) & (USD Million)
Table 140. Asia-Pacific Drug-Device Combination Products Consumption Value by Region (2018-2023) & (USD Million)
Table 141. Asia-Pacific Drug-Device Combination Products Consumption Value by Region (2024-2029) & (USD Million)
Table 142. South America Drug-Device Combination Products Consumption Value by Type (2018-2023) & (USD Million)
Table 143. South America Drug-Device Combination Products Consumption Value by Type (2024-2029) & (USD Million)
Table 144. South America Drug-Device Combination Products Consumption Value by Application (2018-2023) & (USD Million)
Table 145. South America Drug-Device Combination Products Consumption Value by Application (2024-2029) & (USD Million)
Table 146. South America Drug-Device Combination Products Consumption Value by Country (2018-2023) & (USD Million)
Table 147. South America Drug-Device Combination Products Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Middle East & Africa Drug-Device Combination Products Consumption Value by Type (2018-2023) & (USD Million)
Table 149. Middle East & Africa Drug-Device Combination Products Consumption Value by Type (2024-2029) & (USD Million)
Table 150. Middle East & Africa Drug-Device Combination Products Consumption Value by Application (2018-2023) & (USD Million)
Table 151. Middle East & Africa Drug-Device Combination Products Consumption Value by Application (2024-2029) & (USD Million)
Table 152. Middle East & Africa Drug-Device Combination Products Consumption Value by Country (2018-2023) & (USD Million)
Table 153. Middle East & Africa Drug-Device Combination Products Consumption Value by Country (2024-2029) & (USD Million)
Table 154. Drug-Device Combination Products Raw Material
Table 155. Key Suppliers of Drug-Device Combination Products Raw Materials
List of Figures
Figure 1. Drug-Device Combination Products Picture
Figure 2. Global Drug-Device Combination Products Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Drug-Device Combination Products Consumption Value Market Share by Type in 2022
Figure 4. Drug-Coated Device
Figure 5. Prefilled Drug Delivery Systems
Figure 6. Nebulizer and Inhaler
Figure 7. Transdermal Delivery System
Figure 8. Others
Figure 9. Global Drug-Device Combination Products Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Drug-Device Combination Products Consumption Value Market Share by Application in 2022
Figure 11. Hospital andClinic Picture
Figure 12. Retail Pharmacies Picture
Figure 13. Other Picture
Figure 14. Global Drug-Device Combination Products Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Drug-Device Combination Products Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Drug-Device Combination Products Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Drug-Device Combination Products Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Drug-Device Combination Products Consumption Value Market Share by Region in 2022
Figure 19. North America Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Drug-Device Combination Products Revenue Share by Players in 2022
Figure 25. Drug-Device Combination Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Drug-Device Combination Products Market Share in 2022
Figure 27. Global Top 6 Players Drug-Device Combination Products Market Share in 2022
Figure 28. Global Drug-Device Combination Products Consumption Value Share by Type (2018-2023)
Figure 29. Global Drug-Device Combination Products Market Share Forecast by Type (2024-2029)
Figure 30. Global Drug-Device Combination Products Consumption Value Share by Application (2018-2023)
Figure 31. Global Drug-Device Combination Products Market Share Forecast by Application (2024-2029)
Figure 32. North America Drug-Device Combination Products Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Drug-Device Combination Products Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Drug-Device Combination Products Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Drug-Device Combination Products Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Drug-Device Combination Products Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Drug-Device Combination Products Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 42. France Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Drug-Device Combination Products Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Drug-Device Combination Products Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Drug-Device Combination Products Consumption Value Market Share by Region (2018-2029)
Figure 49. China Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 52. India Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Drug-Device Combination Products Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Drug-Device Combination Products Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Drug-Device Combination Products Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Drug-Device Combination Products Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Drug-Device Combination Products Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Drug-Device Combination Products Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Drug-Device Combination Products Consumption Value (2018-2029) & (USD Million)
Figure 66. Drug-Device Combination Products Market Drivers
Figure 67. Drug-Device Combination Products Market Restraints
Figure 68. Drug-Device Combination Products Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Drug-Device Combination Products in 2022
Figure 71. Manufacturing Process Analysis of Drug-Device Combination Products
Figure 72. Drug-Device Combination Products Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
